Sponsor:
LAPIX Therapeutics Inc.
Code:
NCT06982352
Conditions
Atopic Dermatitis (AD)
Psoriasis (PsO)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LPX-TI641
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-26. This information was provided to ClinicalTrials.gov by LAPIX Therapeutics Inc. on 2025-12-19.